Targeting PDE5 with sildenafil has recently gained attention of some researchers as a new therapeutic approach in the treatment of depression (Matsushita et al. 2012; Tomaz et al. 2014; Wang et al. 2014). The gene discussed is PDE5A; the disease is major depressive disorder.